Nov
2026
IICC, Yashobhoomi, Dwarka, Delhi
Visit us
stand 2G07
A R Life sciences Pvt Ltd
Exhibitor at CPHI India 2026
About Us
Categories
-
Country/Region:India
-
On CPHI since:2023
Event information
CPHI India 2026
-
23 Nov 2026 - 25 Nov 2026
-
IICC, Yashobhoomi, Dwarka, Delhi
-
Visit us at stand 2G07
Products Featured at CPHI India 2026
-
Product Abemaciclib Intermediates
1231930-33-8 and 1180132-17-5 -
Product Alogliptin and Linagliptin intermediates
(R)-3-Amino-piperidine dihydrochloride /// (R)-3-(Boc-Amino)piperidine -
Product Dabigatran intermediates
Ethyl 3-(3-amino-4-(methyl amino)-N-(pyridin-2-yl) benzamido) propanoate /// 2-(4-Cyanophenylamino) Acetic Acid -
Product Etrasimod Intermediates
Manufacturing Intermediates of Cas No. 1206124-13-1 and 957208-65-0 -
Product Mirabegron Intermediates
2-(4-nitrophenyl)ethanamine hydrochloride // 2-(2-Aminothiazol-4-yl)acetic acid// R)-2-(4-nitrophenethylamino)-1- Phenylethanol // (R)-2-(4-aminophenethylamino)-1-Phenylethanol HCL
A R Life sciences Pvt Ltd Resources (1)
-
Brochure Product list
A.R. Life sciences ( ARL) is a manufacturer of Bulk Drugs / API’s and Intermediates. The company was established in the year 2007, head office located in Hyderabad, India. Company has an experienced and strong team of 200 + employees with strong client relationships with both International and domestic. ARL has three manufacturing facilities, two located in Hyderabad (One facility USFDA approved) and a brand new facility commencing shortly in Vizag. Infrastructure spread over 10 acres with reactor volume of ~136,000 liters (extendable upto 500,000 liters when fully occupied). Facilities are certified with ISO 9001-2015 and WHO GMP and the company follows cGLP and cGMP practices. In a very short span of time the company has grown into a vertically integrated company specializing in Intermediates and API’s covering various therapeutic areas.
